The primary treatment for patients with type 1 diabetes mellitus (T1D) consists of the combination of glucose monitoring coupled with daily exogenous insulin injections that, despite their effectiveness, do not prevent the challenges associated with daily compliance and T1D secondary complications1. Here, INS is linked to type 1 diabetes mellitus.